FGF23 and X-linked hypophosphatemia: In animal models of XLH and ARHR, the global genetic deletion of Fgf23 completely suppresses FGF23 production, which results in hyperphosphatemia, hypercalcemia, increased vitamin D levels, ectopic calcifications, and early mortality (23–25, 40).